Gelteq Limited (GELS)
- Previous Close
1.9100 - Open
1.9300 - Bid 1.9500 x 100
- Ask 1.9500 x 200
- Day's Range
1.8110 - 2.0200 - 52 Week Range
0.7700 - 5.5000 - Volume
145,803 - Avg. Volume
1,590,609 - Market Cap (intraday)
17.367M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.
www.gelteq.com7
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: GELS
View MorePerformance Overview: GELS
Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GELS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GELS
View MoreValuation Measures
Market Cap
18.03M
Enterprise Value
20.48M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.86
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-8.04%
Return on Equity (ttm)
-21.00%
Revenue (ttm)
143.31k
Net Income Avi to Common (ttm)
-3.55M
Diluted EPS (ttm)
-0.2400
Balance Sheet and Cash Flow
Total Cash (mrq)
24.52k
Total Debt/Equity (mrq)
25.43%
Levered Free Cash Flow (ttm)
-293.77k